Aiolos Bio

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

Latest funding

$245M Series A · November 20, 2023

Led by Atlas Venture · Source: startupintros.com

Funding history ↓

Website: aiolosbio.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biopharma, Biotechnology, Health Care.

Stage: Series A.

Based in: San Francisco, United States.

Founded: 2023.

Last round: Nov 20, 2023 · 1,088 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredSep 29, 2023 (3 years old)

Funding rounds

November 20, 2023
Series A · $245M
AAtlas Venture (lead), BBain Capital Life Sciences (lead), FForbion Capital Partners (lead), SSofinnova Partners (lead), RRA Capital Management
Source: startupintros.com
September 29, 2023
Website created

Founders and team

KF
Khurem Farooq Founder

LinkedIn · also Verdiva Bio
AT
Ashley Taylor Chief Technical Officer

Investors

Companies like Aiolos Bio

NNuvigSeries A · Dec 2024
CCelea Therapeutics$180M Series A · Jul 2026
CClaris Bio$118M Series B+ · Jul 2026
AAltay Therapeutics
KKhartis Therapeutics$95M Series B+ · Aug 2026
MMirador Therapeutics$250M Series B+ · Jan 2026

Other companies backed by Atlas Venture

MMatchpoint Therapeutics$150M Series B+ · Oct 2026
WWHOOP$575M Series B+ · Jun 2026
KKinaset Therapeutics$103M Series B+ · Jan 2026
TTriana Bio$120M Series B+ · Dec 2025
SSunflower Labs$16M Series B+ · Nov 2025
HHealthifyMe$45M Series B+ · Oct 2024

Atlas Venture portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/aiolos-bio (get a free API key).